

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Market Analysis and Insights: Global Artificial Pancreas Devices Systems Market
Due to the COVID-19 pandemic, the global Artificial Pancreas Devices Systems market size is estimated to be worth US$ 89 million in 2022 and is forecast to a readjusted size of US$ 199.8 million by 2029 with a CAGR of 12.1% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Threshold Suspended Device Systems accounting for % of the Artificial Pancreas Devices Systems global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospitals segment is altered to an % CAGR throughout this forecast period.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Global Artificial Pancreas Devices Systems Scope and Market Size
The global Artificial Pancreas Devices Systems market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Artificial Pancreas Devices Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Artificial Pancreas Devices Systems Market Overview
1.1 Artificial Pancreas Devices Systems Product Scope
1.2 Artificial Pancreas Devices Systems Segment by Type
1.2.1 Global Artificial Pancreas Devices Systems Sales by Type (2018 & 2022 & 2029)
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Artificial Pancreas Devices Systems Segment by Application
1.3.1 Global Artificial Pancreas Devices Systems Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Artificial Pancreas Devices Systems Market Estimates and Forecasts (2018-2029)
1.4.1 Global Artificial Pancreas Devices Systems Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Artificial Pancreas Devices Systems Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Artificial Pancreas Devices Systems Price Trends (2018-2029)
2 Artificial Pancreas Devices Systems Estimates and Forecasts by Region
2.1 Global Artificial Pancreas Devices Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Artificial Pancreas Devices Systems Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Artificial Pancreas Devices Systems Sales Market Share by Region (2018-2023)
2.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2018-2023)
2.3 Global Artificial Pancreas Devices Systems Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Artificial Pancreas Devices Systems Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Artificial Pancreas Devices Systems Estimates and Projections (2018-2029)
2.4.2 Europe Artificial Pancreas Devices Systems Estimates and Projections (2018-2029)
2.4.3 China Artificial Pancreas Devices Systems Estimates and Projections (2018-2029)
2.4.4 Japan Artificial Pancreas Devices Systems Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Artificial Pancreas Devices Systems Estimates and Projections (2018-2029)
2.4.6 India Artificial Pancreas Devices Systems Estimates and Projections (2018-2029)
3 Global Artificial Pancreas Devices Systems Competition Landscape by Players
3.1 Global Top Artificial Pancreas Devices Systems Players by Sales (2018-2023)
3.2 Global Top Artificial Pancreas Devices Systems Players by Revenue (2018-2023)
3.3 Global Artificial Pancreas Devices Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Pancreas Devices Systems as of 2022)
3.4 Global Artificial Pancreas Devices Systems Average Price by Company (2018-2023)
3.5 Manufacturers Artificial Pancreas Devices Systems Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Artificial Pancreas Devices Systems Market Size by Type
4.1 Global Artificial Pancreas Devices Systems Historic Market Review by Type (2018-2023)
4.1.1 Global Artificial Pancreas Devices Systems Sales by Type (2018-2023)
4.1.2 Global Artificial Pancreas Devices Systems Revenue by Type (2018-2023)
4.1.3 Global Artificial Pancreas Devices Systems Price by Type (2018-2023)
4.2 Global Artificial Pancreas Devices Systems Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Artificial Pancreas Devices Systems Sales Forecast by Type (2024-2029)
4.2.2 Global Artificial Pancreas Devices Systems Revenue Forecast by Type (2024-2029)
4.2.3 Global Artificial Pancreas Devices Systems Price Forecast by Type (2024-2029)
5 Global Artificial Pancreas Devices Systems Market Size by Application
5.1 Global Artificial Pancreas Devices Systems Historic Market Review by Application (2018-2023)
5.1.1 Global Artificial Pancreas Devices Systems Sales by Application (2018-2023)
5.1.2 Global Artificial Pancreas Devices Systems Revenue by Application (2018-2023)
5.1.3 Global Artificial Pancreas Devices Systems Price by Application (2018-2023)
5.2 Global Artificial Pancreas Devices Systems Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Artificial Pancreas Devices Systems Sales Forecast by Application (2024-2029)
5.2.2 Global Artificial Pancreas Devices Systems Revenue Forecast by Application (2024-2029)
5.2.3 Global Artificial Pancreas Devices Systems Price Forecast by Application (2024-2029)
6 United States Artificial Pancreas Devices Systems Market Facts & Figures
6.1 United States Artificial Pancreas Devices Systems Sales by Company
6.1.1 United States Artificial Pancreas Devices Systems Sales by Company (2018-2023)
6.1.2 United States Artificial Pancreas Devices Systems Revenue by Company (2018-2023)
6.2 United States Artificial Pancreas Devices Systems Sales Breakdown by Type
6.2.1 United States Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
6.2.2 United States Artificial Pancreas Devices Systems Sales Breakdown by Type (2024-2029)
6.3 United States Artificial Pancreas Devices Systems Sales Breakdown by Application
6.3.1 United States Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
6.3.2 United States Artificial Pancreas Devices Systems Sales Breakdown by Application (2024-2029)
7 Europe Artificial Pancreas Devices Systems Market Facts & Figures
7.1 Europe Artificial Pancreas Devices Systems Sales by Company
7.1.1 Europe Artificial Pancreas Devices Systems Sales by Company (2018-2023)
7.1.2 Europe Artificial Pancreas Devices Systems Revenue by Company (2018-2023)
7.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Type
7.2.1 Europe Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
7.2.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Type (2024-2029)
7.3 Europe Artificial Pancreas Devices Systems Sales Breakdown by Application
7.3.1 Europe Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
7.3.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Application (2024-2029)
8 China Artificial Pancreas Devices Systems Market Facts & Figures
8.1 China Artificial Pancreas Devices Systems Sales by Company
8.1.1 China Artificial Pancreas Devices Systems Sales by Company (2018-2023)
8.1.2 China Artificial Pancreas Devices Systems Revenue by Company (2018-2023)
8.2 China Artificial Pancreas Devices Systems Sales Breakdown by Type
8.2.1 China Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
8.2.2 China Artificial Pancreas Devices Systems Sales Breakdown by Type (2024-2029)
8.3 China Artificial Pancreas Devices Systems Sales Breakdown by Application
8.3.1 China Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
8.3.2 China Artificial Pancreas Devices Systems Sales Breakdown by Application (2024-2029)
9 Japan Artificial Pancreas Devices Systems Market Facts & Figures
9.1 Japan Artificial Pancreas Devices Systems Sales by Company
9.1.1 Japan Artificial Pancreas Devices Systems Sales by Company (2018-2023)
9.1.2 Japan Artificial Pancreas Devices Systems Revenue by Company (2018-2023)
9.2 Japan Artificial Pancreas Devices Systems Sales Breakdown by Type
9.2.1 Japan Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
9.2.2 Japan Artificial Pancreas Devices Systems Sales Breakdown by Type (2024-2029)
9.3 Japan Artificial Pancreas Devices Systems Sales Breakdown by Application
9.3.1 Japan Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
9.3.2 Japan Artificial Pancreas Devices Systems Sales Breakdown by Application (2024-2029)
10 Southeast Asia Artificial Pancreas Devices Systems Market Facts & Figures
10.1 Southeast Asia Artificial Pancreas Devices Systems Sales by Company
10.1.1 Southeast Asia Artificial Pancreas Devices Systems Sales by Company (2018-2023)
10.1.2 Southeast Asia Artificial Pancreas Devices Systems Revenue by Company (2018-2023)
10.2 Southeast Asia Artificial Pancreas Devices Systems Sales Breakdown by Type
10.2.1 Southeast Asia Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Artificial Pancreas Devices Systems Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Artificial Pancreas Devices Systems Sales Breakdown by Application
10.3.1 Southeast Asia Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Artificial Pancreas Devices Systems Sales Breakdown by Application (2024-2029)
11 India Artificial Pancreas Devices Systems Market Facts & Figures
11.1 India Artificial Pancreas Devices Systems Sales by Company
11.1.1 India Artificial Pancreas Devices Systems Sales by Company (2018-2023)
11.1.2 India Artificial Pancreas Devices Systems Revenue by Company (2018-2023)
11.2 India Artificial Pancreas Devices Systems Sales Breakdown by Type
11.2.1 India Artificial Pancreas Devices Systems Sales Breakdown by Type (2018-2023)
11.2.2 India Artificial Pancreas Devices Systems Sales Breakdown by Type (2024-2029)
11.3 India Artificial Pancreas Devices Systems Sales Breakdown by Application
11.3.1 India Artificial Pancreas Devices Systems Sales Breakdown by Application (2018-2023)
11.3.2 India Artificial Pancreas Devices Systems Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Artificial Pancreas Devices Systems Business
12.1 Medtronic
12.1.1 Medtronic Corporation Information
12.1.2 Medtronic Business Overview
12.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Medtronic Artificial Pancreas Devices Systems Products Offered
12.1.5 Medtronic Recent Development
12.2 Bigfoot Biomedical
12.2.1 Bigfoot Biomedical Corporation Information
12.2.2 Bigfoot Biomedical Business Overview
12.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Products Offered
12.2.5 Bigfoot Biomedical Recent Development
12.3 Beta Bionics
12.3.1 Beta Bionics Corporation Information
12.3.2 Beta Bionics Business Overview
12.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Beta Bionics Artificial Pancreas Devices Systems Products Offered
12.3.5 Beta Bionics Recent Development
12.4 Admetsys
12.4.1 Admetsys Corporation Information
12.4.2 Admetsys Business Overview
12.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Admetsys Artificial Pancreas Devices Systems Products Offered
12.4.5 Admetsys Recent Development
12.5 Insulet
12.5.1 Insulet Corporation Information
12.5.2 Insulet Business Overview
12.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Insulet Artificial Pancreas Devices Systems Products Offered
12.5.5 Insulet Recent Development
12.6 Tandem Diabetes Care
12.6.1 Tandem Diabetes Care Corporation Information
12.6.2 Tandem Diabetes Care Business Overview
12.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Products Offered
12.6.5 Tandem Diabetes Care Recent Development
12.7 Defymed
12.7.1 Defymed Corporation Information
12.7.2 Defymed Business Overview
12.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Defymed Artificial Pancreas Devices Systems Products Offered
12.7.5 Defymed Recent Development
13 Artificial Pancreas Devices Systems Manufacturing Cost Analysis
13.1 Artificial Pancreas Devices Systems Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Artificial Pancreas Devices Systems
13.4 Artificial Pancreas Devices Systems Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Artificial Pancreas Devices Systems Distributors List
14.3 Artificial Pancreas Devices Systems Customers
15 Market Dynamics
15.1 Artificial Pancreas Devices Systems Industry Trends
15.2 Artificial Pancreas Devices Systems Market Drivers
15.3 Artificial Pancreas Devices Systems Market Challenges
15.4 Artificial Pancreas Devices Systems Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Ìý
Ìý
*If Applicable.